Xlife Sciences recognized the potential of DAZAmed early on and guided the project by the inventors Prof. Dr. Martin Freesmeyer and Dr. Julia Greiser from an academic discovery to clinical readiness: inflamed pharma GmbH established GMP-compliant manufacturing and formulation of the precursor. The x-nuclear diagnostics GmbH drove technical development and translation toward clinical use.

This progress demonstrates our ability to identify high-value innovations early, connect the right expertise and drive them efficiently toward market readiness. The Lothar Späth Award honors the Jena research team and validates the strength of our collaborative model between academia, start-ups and industry.

With DAZAmed, a new era in liver and bile duct diagnostics has already begun. Xlife Sciences AG will continue to actively support its way to commercialization. It reflects the Xlife Sciences model: we don’t just support innovation, we connect the right expertise, accelerate development and help groundbreaking ideas reach patients.

Financial calendar

Xlife Sciences recognized the potential of DAZAmed early on and guided the project by the inventors Prof. Dr. Martin Freesmeyer and Dr. Julia Greiser from an academic discovery to clinical readiness: inflamed pharma GmbH established GMP-compliant manufacturing and formulation of the precursor. The x-nuclear diagnostics GmbH drove technical development and translation toward clinical use.

This progress demonstrates our ability to identify high-value innovations early, connect the right expertise and drive them efficiently toward market readiness. The Lothar Späth Award honors the Jena research team and validates the strength of our collaborative model between academia, start-ups and industry.

With DAZAmed, a new era in liver and bile duct diagnostics has already begun. Xlife Sciences AG will continue to actively support its way to commercialization. It reflects the Xlife Sciences model: we don’t just support innovation, we connect the right expertise, accelerate development and help groundbreaking ideas reach patients.

Financial calendar